RICI HEALTH1526.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, RICI HEALTH (1526.HK) trades at a P/E of 4.17x, P/B of 0.72x, P/S of 0.44x, and a dividend yield of 2.28%.
Longitudinal percentile comparison: P/E sits at the 19th percentile over the trailing 10Y window (vs. 20th percentile over 3Y); P/B sits at the 2nd percentile over the trailing 10Y window (vs. 8th percentile over 3Y); P/S sits at the 13th percentile over the trailing 10Y window (vs. 12th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 5th percentile within its industry and the 13th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.52%, ranking at the 88th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 16.8 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 2.52% total shareholder yield, 2.28% is paid out as dividends and roughly 0.24% is implied to come from buybacks — both channels are meaningfully in play. RICI HEALTH operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1526 · SEHK: 1526 · 1526
Want the full picture on whether RICI HEALTH (1526.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 4.17 | ||||||
| P/B (MRQ) | 0.72 | ||||||
| P/S (TTM) | 0.44 | ||||||
| Dividend Yield | 2.28% | ||||||
| Buyback + Div Yield | 2.52% |